Galmed Pharmaceuticals Ltd

Nasdaq EOCN · Ramat Gan, Israel

Works in GI & liver

Galmed Pharmaceuticals Ltd is a clinical trial sponsor based in Ramat Gan, Israel, listed as Nasdaq EOCN. It has 1 active clinical trial with 32 planned participants, in GI & liver. Since 2021 it has completed 3 trials and stopped 1 early.

Trial track record · since 2021

1Active trials32 planned participants
3Completed1 with results posted
1Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq EOCN

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 1 active trial

StageTrialStatus

Questions about Galmed Pharmaceuticals Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-10.

Approve Suite is not affiliated with Galmed Pharmaceuticals Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.